Accepted for Publication: December 2, 2017.
Corresponding Author: Lene Vestergaard Ravn-Nielsen, MSc(Pharm), Hospital Pharmacy of Funen, Clinical Pharmacy Department, Odense University Hospital, Solfaldsvej 38, DK-5000 Odense C, Denmark (leneravn.nielsen@gmail.com).
Published Online: January 29, 2018. doi:10.1001/jamainternmed.2017.8274
Author Contributions: Ms Ravn-Nielsen had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Ravn-Nielsen, Eriksen, Buck, Hansen, Hallas.
Acquisition, analysis, or interpretation of data: Ravn-Nielsen, Duckert, Lund, Henriksen, Nielsen, Eriksen, Pottegård, Hansen, Hallas.
Drafting of the manuscript: Ravn-Nielsen, Duckert, Nielsen, Pottegård, Hallas.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Pottegård.
Obtained funding: Ravn-Nielsen, Buck, Hallas.
Administrative, technical, or material support: Duckert, Henriksen, Nielsen, Buck, Hansen, Hallas.
Study supervision: Lund, Pottegård, Hansen, Hallas.
Conflict of Interest Disclosures: Ms Ravn-Nielsen reported receiving grants from the Hospitals Pharmacies’ and Amgros’ Research Development Foundation, 2 public regional foundations, and the Actavis Foundation during the conduct of the study. Dr Hansen reported receiving grants from Menarini and Pfizer unrelated to this project and personally receiving fees from the Danish Association of Pharmaceutical Manufacturers. Dr Hallas reported participating in research projects funded by Novartis, Pfizer, Menarini, MSD, Nycomed, Leo Pharmaceuticals, Astellas, and Alk-Abelló with grants paid to the institution where he was employed and personally receiving fees from the Danish Association of Pharmaceutical Manufacturers, Pfizer, and Menarini unrelated to this project. No other disclosures were reported.
Funding/Support: This study was supported by unrestricted grants from The Hospitals Pharmacies’ and Amgros’ Research Development Foundation, public regional research foundations for Southern Denmark and Zealand, and the Actavis Foundation.
Role of the Funder/Sponsor: The funding organizations had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: Lisbeth Muurholm, MSc(Pharm), Hospital Pharmacy of Funen, Odense, Denmark, ensured the organizational base for this study. We thank the intervention pharmacists from Odense University Hospital, Odense and Svendborg; the personnel involved from the Hospital Pharmacy of Funen; the clinical pharmacists from Viborg Regional Hospital, Viborg, Denmark, and Holbæk Hospital, Holbæk, Denmark; and all the participating wards, patients, physicians, nurses, general practitioners, nursing homes, and pharmacy personnel from primary care and the impartial clinical pharmacologist.
1.Beijer
HJM, de Blaey
CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies.
Pharm World Sci. 2002;24(2):46-54.
PubMedGoogle ScholarCrossref 2.Kongkaew
C, Noyce
PR, Ashcroft
DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.
Ann Pharmacother. 2008;42(7):1017-1025.
PubMedGoogle ScholarCrossref 3.Hallas
J, Gram
LF, Grodum
E,
et al. Drug related admissions to medical wards: a population based survey.
Br J Clin Pharmacol. 1992;33(1):61-68.
PubMedGoogle ScholarCrossref 4.Cunningham
G, Dodd
TR, Grant
DJ, McMurdo
ME, Richards
RM. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment.
Age Ageing. 1997;26(5):375-382.
PubMedGoogle ScholarCrossref 5.Mannesse
CK, Derkx
FH, de Ridder
MA, Man in ’t Veld
AJ, van der Cammen
TJ. Contribution of adverse drug reactions to hospital admission of older patients.
Age Ageing. 2000;29(1):35-39.
PubMedGoogle ScholarCrossref 6.Patel
NS, Patel
TK, Patel
PB, Naik
VN, Tripathi
CB. Hospitalizations due to preventable adverse reactions: a systematic review.
Eur J Clin Pharmacol. 2017;73(4):385-398.
PubMedGoogle ScholarCrossref 7.Christensen
HR, Krølner
BK. Medication problems in connection with transferral between sectors [in Danish].
Ugeskr Laeger. 2009;171(10):808-811.
PubMedGoogle Scholar 8.Karapinar-Carkit
F, Borgsteede
SD, Zoer
J,
et al. The effect of the COACH program (Continuity of Appropriate Pharmacotherapy, Patient Counselling and Information Transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients.
BMC Health Serv Res. 2010;10:39.
PubMedGoogle ScholarCrossref 9.Midlöv
P, Bergkvist
A, Bondesson
A, Eriksson
T, Höglund
P. Medication errors when transferring elderly patients between primary health care and hospital care.
Pharm World Sci. 2005;27(2):116-120.
PubMedGoogle ScholarCrossref 10.Knez
L, Suskovic
S, Rezonja
R, Laaksonen
R, Mrhar
A. The need for medication reconciliation: a cross-sectional observational study in adult patients.
Respir Med. 2011;105(suppl 1):S60-S66.
PubMedGoogle ScholarCrossref 11.Uitvlugt
EB, Suijker
R, Janssen
MJA, Siegert
CEH, Karapinar-Çarkit
F. Quality of medication related information in discharge letters: A prospective cohort study. [published online October 7, 2017].
Eur J Intern Med. 2017;46:e23-e25. doi:
10.1016/j.ejim.2017.09.015PubMedGoogle ScholarCrossref 12.Carter
BL, Farris
KB, Abramowitz
PW,
et al. The Iowa Continuity of Care study: background and methods.
Am J Health Syst Pharm. 2008;65(17):1631-1642.
PubMedGoogle ScholarCrossref 13.Graabaek
T, Kjeldsen
LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review.
Basic Clin Pharmacol Toxicol. 2013;112(6):359-373.
PubMedGoogle ScholarCrossref 14.Bergkvist
A, Midlöv
P, Höglund
P, Larsson
L, Bondesson
A, Eriksson
T. Improved quality in the hospital discharge summary reduces medication errors—LIMM: Landskrona Integrated Medicines Management.
Eur J Clin Pharmacol. 2009;65(10):1037-1046.
PubMedGoogle ScholarCrossref 15.Midlöv
P, Holmdahl
L, Eriksson
T,
et al. Medication report reduces number of medication errors when elderly patients are discharged from hospital.
Pharm World Sci. 2008;30(1):92-98.
PubMedGoogle ScholarCrossref 16.Midlöv
P, Deierborg
E, Holmdahl
L, Höglund
P, Eriksson
T. Clinical outcomes from the use of Medication Report when elderly patients are discharged from hospital.
Pharm World Sci. 2008;30(6):840-845.
PubMedGoogle ScholarCrossref 17.Holland
R, Desborough
J, Goodyer
L, Hall
S, Wright
D, Loke
YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? a systematic review and meta-analysis.
Br J Clin Pharmacol. 2008;65(3):303-316.
PubMedGoogle ScholarCrossref 18.Mekonnen
AB, McLachlan
AJ, Brien
J-AE. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis.
BMJ Open. 2016;6(2):e010003.
PubMedGoogle ScholarCrossref 19.Grimes
TC, Breslin
N, Deasy
E,
et al. Comment on: pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis.
J Clin Pharm Ther. 2016;41(6):739-740.
PubMedGoogle ScholarCrossref 20.Nieuwlaat
R, Wilczynski
N, Navarro
T,
et al. Interventions for enhancing medication adherence.
Cochrane Database Syst Rev. 2014;(11):CD000011.
PubMedGoogle Scholar 21.Christensen
M, Lundh
A. Medication review in hospitalised patients to reduce morbidity and mortality.
Cochrane Database Syst Rev. 2016;2(2):CD008986.
PubMedGoogle Scholar 22.Levy
HB. Polypharmacy reduction strategies: tips on incorporating American Geriatrics Society Beers and Screening Tool of Older People’s Prescriptions criteria.
Clin Geriatr Med. 2017;33(2):177-187.
PubMedGoogle ScholarCrossref 23.Graabæk
T, Bonnerup
DK, Kjeldsen
LJ, Rossing
C, Pottegård
A. Pharmacist-led medication review in an acute admissions unit: a systematic procedure description.
Eur J Hosp Pharm Sci Pract. 2015;22(4):202.
Google ScholarCrossref 24.Pirmohamed
M, James
S, Meakin
S,
et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.
BMJ. 2004;329(7456):15-19.
PubMedGoogle ScholarCrossref 25.Cua
YM, Kripalani
S. Medication use in the transition from hospital to home.
Ann Acad Med Singapore. 2008;37(2):136.
PubMedGoogle Scholar 26.Poole
DL, Chainakul
JN, Pearson
M, Graham
L. Medication reconciliation: a necessity in promoting a safe hospital discharge.
J Healthc Qual. 2006;28(3):12-19.
PubMedGoogle ScholarCrossref 27.Britt
E, Hudson
SM, Blampied
NM. Motivational interviewing in health settings: a review.
Patient Educ Couns. 2004;53(2):147-155.
PubMedGoogle ScholarCrossref 29.Doucette
WR, Farris
KB, Youland
KM, Newland
BA, Egerton
SJ, Barnes
JM. Development of the Drug Adherence Work-up (DRAW) tool.
J Am Pharm Assoc (2003). 2012;52(6):e199-e204.
PubMedGoogle ScholarCrossref 31.Schmidt
M, Schmidt
SAJ, Sandegaard
JL, Ehrenstein
V, Pedersen
L, Sørensen
HT. The Danish National Patient Registry: a review of content, data quality, and research potential.
Clin Epidemiol. 2015;7(Nov):449-490.
PubMedGoogle ScholarCrossref 32.Hallas
J, Harvald
B, Gram
LF,
et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention.
J Intern Med. 1990;228(2):83-90.
PubMedGoogle ScholarCrossref 34.Naranjo
CA, Busto
U, Sellers
EM,
et al. A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther. 1981;30(2):239-245.
PubMedGoogle ScholarCrossref 35.Hansen
TG. Medicines Management Among Elderly Patients: Evidence, Procedure, Outcome and a New Approach [thesis]. Odense: University of Southern Denmark; 2016.
39.Gillespie
U, Alassaad
A, Henrohn
D,
et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial.
Arch Intern Med. 2009;169(9):894-900.
PubMedGoogle ScholarCrossref 40.Olesen
C, Harbig
P, Buus
KM, Barat
I, Damsgaard
EM. Impact of pharmaceutical care on adherence, hospitalisations and mortality in elderly patients.
Int J Clin Pharm. 2014;36(1):163-171.
PubMedGoogle ScholarCrossref 41.Brayne
C, Gao
L, Dewey
M, Matthews
FE; Medical Research Council Cognitive Function and Ageing Study Investigators. Dementia before death in ageing societies— the promise of prevention and the reality. PLoS Med. 2006;3(10):e397.
42.Saedder
EA, Lisby
M, Nielsen
LP,
et al. Detection of patients at high risk of medication errors: development and validation of an algorithm.
Basic Clin Pharmacol Toxicol. 2016;118(2):143-149.
PubMedGoogle ScholarCrossref